Radical transparency

What we don't offer, and why

Most companies publish a catalog. Here's the opposite: the peptides we will not sell, with the reason for each. Several are among the most requested on the internet.

The rule behind the list

Peptaven will offer a therapy only when two conditions are true: it is legally available through a licensed US pharmacy, and a licensed provider can appropriately prescribe it after reviewing an individual patient. Demand is not one of the conditions. Neither is margin.

BPC-157

Not yet legal

Removed from FDA Category 2 in April 2026; recommended for the 503A bulks list by an 8–6 advisory vote (one abstention) in July 2026, reviewed in the context of ulcerative colitis. Rulemaking incomplete — not legally compoundable today. Prohibited by WADA.

TB-500

Not yet legal

Recommended for the 503A bulks list at the July 2026 advisory meeting. Human clinical evidence remains limited. Rulemaking incomplete — not legally compoundable today.

KPV

Not yet legal

A short tripeptide derived from alpha-MSH, studied for anti-inflammatory activity. Recommended at the July 2026 advisory meeting; rulemaking incomplete.

MOTs-c

Not yet legal

A mitochondrial-derived peptide studied in metabolic and exercise-biology research. Recommended at the July 2026 advisory meeting; rulemaking incomplete.

Epitalon

Not yet legal

Studied primarily in early-stage and non-human longevity research. Recommended at the July 2026 advisory meeting; rulemaking incomplete.

Semax

Not yet legal

Studied for cognitive and neuroprotective effects, largely in research conducted outside the US. Recommended at the July 2026 advisory meeting; rulemaking incomplete.

Emideltide

Not available

The one peptide reviewed at the July 2026 meeting that the advisory committee voted NOT to recommend for the 503A bulks list.

Melanotan II

Not available

Widely sold online despite not being legally available for human use in the US. Associated with documented safety concerns.

GHK-Cu (injectable)

Not available

Copper peptide studied for skin and tissue effects. Topical cosmetic formulations exist; the injectable form is not legally available for human use in the US.

DSIP

Not available

Sold widely under research-use labeling; not legally available for human use in the US.

Ipamorelin

Not available

A growth-hormone secretagogue that has been restricted for compounding by the FDA. Frequently marketed online regardless.

Why would a company advertise what it won't sell?

Because in this category, what a seller refuses to offer tells you more than what it stocks. Any site willing to sell you anything you ask for is telling you its supply chain has no gatekeeper.

Will these become available later?

Some may. Several peptides received a favorable advisory recommendation in July 2026 and could become legally compoundable if the FDA completes rulemaking. If and when that happens, we will say so — and only then consider offering them.

Can I get these somewhere else?

You can find most of them sold online today under 'research use only' labeling. That is not a legal pathway for human use, and it means no prescriber, no licensed pharmacy, and no verified purity or sterility. We don't recommend it.